MBX Biosciences, Inc.

Ownership Transactions Reported by 23 Insiders

Symbol
MBX on Nasdaq
Industry
Pharmaceutical Preparations
Location
11711 N. Meridian Street, Suite 300, Carmel, IN

Insiders trading volume in the past year

MBX Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Frazier Life Sciences X, L.P. 10%+ Owner $48.7M Sep 16, 2024
Patrick J. Heron Director, 10%+ Owner $48.7M Sep 16, 2024
Paul Edward Walker 10%+ Owner $38.6M Sep 16, 2024
Scott D. Sandell 10%+ Owner $38.6M Sep 16, 2024
Edward T. Mathers Director, 10%+ Owner $38.6M Sep 16, 2024
Mohamad Makhzoumi 10%+ Owner $38.6M Sep 16, 2024
Anthony A. Florence Jr. 10%+ Owner $38.6M Sep 16, 2024
Carmen Chang 10%+ Owner $38.6M Sep 16, 2024
New Enterprise Associates 17, L.P. 10%+ Owner $38.6M Sep 16, 2024
Forest Baskett 10%+ Owner $38.6M Sep 16, 2024
Rick Yang 10%+ Owner $38.6M Sep 16, 2024
Ali Behbahani 10%+ Owner $38.6M Sep 16, 2024
Tiba Aynechi Director $22.8M Sep 16, 2024
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10%+ Owner $19.1M Sep 16, 2024
P. Kent Hawryluk President & CEO, Director $9.94M +$535K +5.68% Feb 3, 2025
Orbimed Advisors Llc Director, 10%+ Owner $8.11M +$2.02M +33.2% Feb 14, 2025
Carl L. Gordon Director, 10%+ Owner $8.11M +$2.02M +33.2% Feb 14, 2025
James M. Cornelius Director $1.09M Sep 16, 2024
Ora H. Pescovitz Director $143K +$45.3K +46.2% Apr 8, 2025
Steven Ryder Director Sep 12, 2024
Salomon Azoulay Chief Medical Officer Feb 3, 2025
Richard Bartram Chief Financial Officer Feb 3, 2025
Steven L. Hoerter Director Apr 7, 2025

Recent Insider Transactions by Companies or Individuals for MBX Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.